2026 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Nov 12 - Nov 16, 2026
- Title: Oral Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks: The Phase 3 CHAPTER-3 Trial
Presenter: Marc A. Riedl, M.D., M.S.
Format: Oral Presentation
Date, time: Saturday, November 14, 2026, 5:33 p.m. MST (7:33 p.m. EST) - Title: Early and Sustained Effects of Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks
Presenter: John Anderson, M.D.
Format: Poster Presentation
Date, time: Friday, November 13, 2026, 5:05 p.m. MST (7:05 p.m. EST) - Title: Economic Burden and Treatment Patterns Among Individuals With Hereditary Angioedema: a U.S. Closed Claims Analysis
Presenter: Raffi Tachdjian, M.D., MPH
Format: Poster Presentation
Date, time: Saturday, November 14, 2026, 12:45 p.m. MST (2:45 p.m. EST) - Title: Oral Deucrictibant for Prophylaxis of Hereditary Angioedema Attacks: Final Results From the CHAPTER-1 Open-Label Extension
Presenter: Michael E. Manning, M.D.
Format: Poster Presentation
Date, time: Sunday, November 15, 2026, 11:45 a.m. MST (1:45 p.m. EST) - Title: Clinical Cardiovascular Safety Evaluation of Oral Deucrictibant
Presenter: Anne Lesage, Ph.D.
Format: Poster Presentation
Date, time: Sunday, November 15, 2026, 12:15 p.m. MST (2:15 p.m. EST) - Title: Evaluation of Safety Margins and Response to Deucrictibant Immediate-Release Capsule Combined With Deucrictibant Extended-Release Tablet
Presenter: Anne Lesage, Ph.D.
Format: Poster Presentation
Date, time: Sunday, November 15, 2026, 12:30 p.m. MST (2:30 p.m. EST)